NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Wednesday, July 11th. Investors of record on Wednesday, July 25th will be given a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 dividend on an annualized basis and a yield of 2.71%. The ex-dividend date is Tuesday, July 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) announced its quarterly earnings data on Wednesday, August, 8th. The pharmacy operator reported $1.69 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.61 by $0.08. The pharmacy operator had revenue of $46.71 billion for the quarter, compared to analysts' expectations of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. CVS Health's quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.33 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Monday, November, 5th 2018. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY18 earnings guidance on Wednesday, August, 8th. The company provided earnings per share (EPS) guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.00. CVS Health also updated its Q3 guidance to $1.68-1.73 EPS.

17 Wall Street analysts have issued 12 month target prices for CVS Health's shares. Their forecasts range from $68.00 to $99.00. On average, they anticipate CVS Health's stock price to reach $86.6667 in the next twelve months. This suggests a possible upside of 17.6% from the stock's current price. View Analyst Price Targets for CVS Health.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 4 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

CVS Health saw a increase in short interest during the month of July. As of July 31st, there was short interest totalling 50,796,244 shares, an increase of 8.2% from the July 13th total of 46,962,651 shares. Based on an average trading volume of 5,911,694 shares, the days-to-cover ratio is currently 8.6 days. Approximately 5.0% of the shares of the stock are sold short. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Headlines about CVS stock have been trending positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. CVS Health earned a media and rumor sentiment score of 0.28 on Accern's scale. They also gave media headlines about the pharmacy operator an impact score of 47.35 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for CVS Health.

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.29%), FMR LLC (2.83%), Parnassus Investments CA (1.64%), Bank of New York Mellon Corp (1.24%), Veritas Asset Management LLP (1.17%) and Dimensional Fund Advisors LP (1.07%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Bank of America Corp DE, Bank of Montreal Can, Massachusetts Financial Services Co. MA, Canada Pension Plan Investment Board, Standard Life Aberdeen plc, American Century Companies Inc. and NN Investment Partners Holdings N.V.. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Charles Schwab Investment Advisory Inc., Boston Partners, Morgan Stanley, Caisse DE Depot ET Placement DU Quebec, Bank of New York Mellon Corp, Fiera Capital Corp and Natixis. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $73.68.

CVS Health has a market capitalization of $70.30 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]